Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
Completed · Phase 2
Conditions studied: Schizophrenia
In brief
The purpose of this study is to demonstrate that AZD3480 improves cognition in patients with stable schizophrenia who are being treated with an atypical antipsychotic and who are active cigarette smokers, to assess the safety and tolerability of AZD3480 and to define the optimal dose(s) to be used in future trials.
Key facts
- Study ID
- NCT00528905
- Run by
- AstraZeneca
- People needed
- 400
- Starts
- 2007-08-01
- Expected to finish
- 2008-11-01
- Last updated by the study team
- 2008-11-25
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of schizophrenia
- Outpatient at the time of screening and randomization
- Stable housing defined as having a place to live in the community (ie, not in a hospital or nursing home)
- Active cigarette smoking (10 or more cigarettes per day
You may not qualify if…
- Any significant psychiatric or neurological disease other than schizophrenia, or current diagnosis of major depressive disorder
- Known or suspected drug or alcohol abuse within the 6 months or urine toxicology test positive for illegal or non-prescribed substances
- Impaired vision and/or hearing making cognitive testing difficult
Where it is running
- Research Site — Anaheim, California, United States
- Research Site — Cerritos, California, United States
- Research Site — Costa Mesa, California, United States
- Research Site — Escondido, California, United States
- Research Site — Garden Grove, California, United States
- Research Site — Long Beach, California, United States
- Research Site — Los Angeles, California, United States
- Research Site — Oceanside, California, United States
- Research Site — Pasadena, California, United States
- Research Site — Pico Rivera, California, United States
- Research Site — San Diego, California, United States
- Research Site — Santa Ana, California, United States
- Research Site — New Britain, Connecticut, United States
- Research Site — New Haven, Connecticut, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Boca Raton, Florida, United States
- Research Site — Coral Gables, Florida, United States
- Research Site — North Miami, Florida, United States
- Research Site — Orlando, Florida, United States
- Research Site — Tampa, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Augusta, Georgia, United States
- Research Site — Marietta, Georgia, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.